Rocket Pharmaceuticals Inc (RCKT)
$2.44 -3.94% Close Oct 30, 2026 Live
Rocket Pharmaceuticals stock today
Rocket Pharmaceuticals closed at $2.44 on October 30, 2026, down 3.94% on the day. Over the past year it returned -34.1% with dividends reinvested, against +12.4% for the S&P 500. Its market value is $266 million.
$2.00$3.00$4.00$5.00
NovJan 2026MarMayJulSep
| Period | RCKT | S&P 500 (SPY) |
|---|---|---|
| 1 month | -7.2% | -0.9% |
| 3 months | -24.0% | +2.1% |
| Year to date | -30.5% | +11.7% |
| 1 year | -34.1% | +12.4% |
| 3 years | -86.7% | +88.5% |
| 5 years | -91.8% | +76.0% |
Key statistics
- Market value
- $266M
- 52-week range
- $2.18 to $5.30
- Next report
- Nov 5, 2026 (estimated)
About Rocket Pharmaceuticals
Develops gene therapy treatments for genetic disorders.
Sector: Health Care
More on Rocket Pharmaceuticals
- Returns: what $1,000 became$1,000 ten years ago is $85.32 today
No forecast, no recommendation. This page describes Rocket Pharmaceuticals Inc from published data; it is not advice to buy, sell or hold any security.
Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.